Geode Capital Management
DRTS icon

Geode Capital Management’s Alpha Tau Medical DRTS Stock Holding History

Geode Capital Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$378K Buy
53,399
+15,506
+41% +$109K ﹤0.01% 3687
2025
Q4 		$188K Hold
37,893
– – ﹤0.01% 3926
2025
Q3 		$171K Hold
37,893
– – ﹤0.01% 3974
2025
Q2 		$118K Hold
37,893
– – ﹤0.01% 4018
2025
Q1 		$95.1K Hold
37,893
– – ﹤0.01% 4043
2024
Q4 		$117K Buy
37,893
+2,177
+6% +$5.57K ﹤0.01% 4058
2024
Q3 		$85K Hold
35,716
– – ﹤0.01% 4150
2024
Q2 		$90.4K Hold
35,716
– – ﹤0.01% 4162
2024
Q1 		$105K Hold
35,716
– – ﹤0.01% 4146
2023
Q4 		$108K Hold
35,716
– – ﹤0.01% 4169
2023
Q3 		$135K Buy
35,716
+2,640
+8% +$9.67K ﹤0.01% 4141
2023
Q2 		$145K Buy
33,076
+6,470
+24% +$23.2K ﹤0.01% 4187
2023
Q1 		$76.4K Buy
26,606
+6,364
+31% +$22.2K ﹤0.01% 4424
2022
Q4 		$64K Hold
20,242
– – ﹤0.01% 4522
2022
Q3 		$118K Hold
20,242
– – ﹤0.01% 4495
2022
Q2 		$182K Buy
+20,242
New +$181K ﹤0.01% 4324

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Geode Capital Management's DRTS Position: Q1 2026 in Review

Geode Capital Management increased its Alpha Tau Medical (DRTS) stake by 41% in Q1 2026, buying an estimated $109K and bringing the position to 53,399 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

Geode Capital Management first reported a position in DRTS in Q2 2022 and has held it in 16 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Geode Capital Management held 53,399 shares of Alpha Tau Medical worth $378K as of Q1 2026.
  • Geode Capital Management bought 15,506 Alpha Tau Medical shares in Q1 2026, an estimated $109K.
  • Alpha Tau Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3687 holding.
  • Geode Capital Management first reported a position in Alpha Tau Medical in Q2 2022 and has held it in 16 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.